All Atlantic Canada provinces have confirmed commitment to fund the drug
Read MoreNews
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
Cystic Fibrosis Canada calls on remaining jurisdictions to fund the drug
Read MoreNewfoundland and Labrador is the only Atlantic Canada province yet to confirm it will fund the drug. Prince Edward Island (PEI) is the latest province to announce it will fund the transformational cystic fibrosis drug, Trikafta.
Read MoreOver 50 CF medical experts from across Canada have added their names to the open letter to provincial governments calling for access for everyone who could benefit from it.
Read MoreCommunity consultation program will enable people impacted by cystic fibrosis to provide input, insights and perspectives
Read MoreCystic Fibrosis Canada calls on remaining provinces to save lives and list Trikafta immediately
Read MoreCystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs
Read MoreProvinces pressed to save lives by following guidance from CF clinicians, and fund Trikafta now for all Canadians who can benefit
Read MoreA letter has been sent to the Honourable François Legault, Premier of the Province of Quebec, and Christian Dubé, Minister of Health, regarding the INESSS recommendation for the cystic fibrosis drug, Trikafta.
Read More